The Poultry Vaccines Market Size accounted for USD 1,752.1 Million in 2022 and is estimated to achieve a market size of USD 3,580.8 Million by 2032 growing at a CAGR of 7.5% from 2023 to 2032.
Poultry Vaccines Market Highlights
- Global poultry vaccines market revenue is poised to garner USD 3,580.8 million by 2032 with a CAGR of 7.5% from 2023 to 2032
- North America poultry vaccines market value occupied around USD 718.3 million in 2022
- Asia-Pacific poultry vaccines market growth will record a CAGR of more than 8.4% from 2023 to 2032
- Among product, the attenuated live vaccines sub-segment generated over US$ 543.2 million revenue in 2022
- Based on application, the breeder sub-segment generated around 36% share in 2022
- Increasing usage of inactivated vaccines is a popular market trend that fuels the industry demand
Poultry vaccines are primarily used to prevent and control infectious poultry diseases. Their application in poultry farming is intended to prevent or reduce the emergence of active diseases at the farm level, thereby increasing production. Vaccines and vaccination programs vary significantly depending on various local factors, such as farming type, disease trends, costs, and potential losses. These programs are generally managed by the poultry sector. In the last decade, the economic losses caused by major chronic poultry diseases, such as avian influenza and Newcastle disease, have been massive for both the commercial and public sectors. However, vaccination should be used in the context of national or regional poultry disease eradication programs overseen by public veterinary services.
Global Poultry Vaccines Market Dynamics
Market Drivers
- Increasing incidences of poultry diseases
- Growing occurrence of zoonotic diseases
- Rising consumption of poultry-derived products
- Widened focus on food standards and safety
Market Restraints
- Increasing cost of the vaccines
- Rising acceptance of vegan and vegetarian food
- Side-effects of poultry vaccines
Market Opportunities
- Increasing government involvement in poultry treatment
- Leading industries expanding their vaccination programs
- Rising prevalence of avian influenza
Poultry Vaccines Market Report Coverage
| Market |
Poultry Vaccines Market
|
| Poultry Vaccines Market Size 2022 |
USD 1,752.1 Million |
| Poultry Vaccines Market Forecast 2032 |
USD 3,580.8 Million |
| Poultry Vaccines Market CAGR During 2023 - 2032 |
7.5% |
| Poultry Vaccines Market Analysis Period |
2020 - 2032 |
Base Year
|
2022 |
| Forecast Data |
2023 - 2032 |
| Segments Covered |
By Disease, By Product, By Dosage Form, By Technology, By Application, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Boehringer Ingelheim International GmbH, Zoetis, Ceva Animal Health, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Ringpu Biology, Anicon GmbH, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Poultry Vaccines Market Insights
Increase the importance of vaccination in poultry farms will drive the growth of the market. Vaccination plays a significant role in maintaining the health of poultry farms. It helps prevent various poultry diseases through a controlled process where healthy birds are exposed to weakened or inactivated pathogens. After vaccination, the birds' immune systems respond by mobilizing a specialized defense mechanism designed to detect and eliminate the invading pathogens before they can harm the birds. This process also leads to the formation of memory cells, which can recognize the specific pathogens the birds have been immunized against. As a result, if the pathogens are encountered later in life, the immune system can swiftly identify and neutralize them, providing disease protection and preserving the overall health of the flock.
Variability in disease challenges vaccine research and development is a restraint for the market. The continual evolution and variety of poultry diseases is a significant limitation in the poultry vaccines market. Pathogen strains and mutations evolve on a regular basis, making it difficult to produce vaccines that give broad-spectrum protection. This diversity can contribute to longer R&D procedures and higher vaccine development costs, impeding timely responses to new poultry health problems.
Growing demand for Antibiotic-Free poultry production is a opportunity for the market. The growing consumer desire for antibiotic-free poultry products creates a business opportunity. With mounting worries about antibiotic resistance and a desire for healthier chicken options, there is a growing demand for vaccines that might aid in the maintenance of poultry health without the use of antibiotics. Vaccine producers can capitalize on this trend by producing and distributing vaccines specifically designed to assist antibiotic-free chicken production, thus addressing the interests of both health-conscious consumers and the poultry sector.
Poultry Vaccines Market Segmentation
The worldwide market for poultry vaccines is split based on disease, product, dosage form, technology, application, end-user, and geography.
Poultry Vaccine Diseases
- Avian Influenza
- Infectious Bronchitis
- Newcastle Disease
- Marek's Disease
- Others
Avian influenza, also known as bird flu, is a disease associated with avian (bird) influenza (flu) Type A viruses. These viruses naturally circulate among wild aquatic birds worldwide and can infect domestic and household poultry, as well as other bird and animal species. Typically, bird flu viruses do not infect humans. Human infections with bird flu viruses have occurred sporadically. Recently, avian influenza A (H7N9) has been reported in China and detected in poultry. While some cases have resulted in mild illness, the majority of patients have experienced severe respiratory problems, and sadly, some have succumbed to the disease.
Poultry Vaccine Products
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Recombinant Vaccines
- DNA Vaccines
Live attenuated vaccines are derived from living bacteria or viruses that have been modified to weaken and reduce their virulence. These vaccines trigger a robust immune response and, in many cases, provide lifelong immunity after just one or two doses. Compared to other vaccines, they have the ability to stimulate the immune system to produce a higher number of antibodies. Moreover, immunization with live attenuated vaccines is more effective and provides protection against avian diseases such as infectious bursal disease, infectious bronchitis, and Newcastle disease. Additionally, increasing research and development (R&D) activities, particularly in the field of vaccination, are driving advancements in this segment, helping to control various outbreaks of the aforementioned diseases.
Poultry Vaccine Dosage Forms
- Liquid Vaccine
- Freeze Dried Vaccine
- Duct
The freeze dried vaccine segment accounts for the majority of the poultry vaccines market. This significance is attributable to a number of important causes. Freeze-dried vaccines are more stable and have a longer shelf life, making them appropriate for storage and transportation in a variety of environments. Furthermore, they are simple to reconstitute prior to injection, making the immunization process easier. These characteristics make freeze-dried vaccines a favoured choice for chicken farmers and vaccination programmes, leading to their market dominance. The ease of use, efficacy, and portability of freeze-dried vaccinations have led to their extensive use in the chicken industry.
Poultry Vaccine Technologies
- Recombinant Vaccines
- Inactivated Vaccines
- Live Attenuated Vaccines (LAV)
- Others
The Live Attenuated Vaccines (LAV) segment is the largest in the poultry vaccines market. This is primarily due to the presence of weakened, but still active, microorganisms that closely mimic disease-causing agents in live attenuated vaccines. This resemblance prompts a strong and long-lasting immunological response in chickens. Live attenuated vaccines provide a high level of protection, effectively lowering the prevalence of poultry illnesses. Their efficacy and low cost make them the ideal choice for poultry vaccination programmes, leading to their market domination. The widespread use of live attenuated vaccines in the poultry industry is a major contributor to this segment's dominance.
Poultry Vaccine Applications
The breeding stock application segment played a dominant role in the market in 2020, primarily due to the increasing adoption of vaccines at breeder farms. These vaccines are instrumental in safeguarding poultry health and significantly enhancing farm productivity. This trend has been particularly pronounced as a result of proactive government initiatives that encourage poultry farming. Consequently, the poultry industry has witnessed a surge in the number of poultry farmers, breeder farms, integrators, and nutrient mills.
Poultry Vaccine End-Users
- Veterinary Hospitals
- Poultry Firm
- Poultry Vaccination Center
Local chicken poultry farms are a valuable resource that helps impoverished people in developing nations to improve their lives. Household or domestic chicken production provides food and income and is an essential component of rural poor food security. However, widespread poultry diseases, overexploitation, and poor production practices are among the challenges to village poultry's productive output. As a result of these factors, demand for the poultry vaccination center segment is expected to rise in the forecasting period.
Poultry Vaccines Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Poultry Vaccines Market Regional Analysis
North America dominates the poultry vaccines market, with the biggest market share. This is partly because the poultry industries in the United States and Canada are so advanced. The region's chicken farming practices are distinguished by a significant emphasis on disease control, biosecurity measures, and technical improvements, positioning it as a market leader.
Following closely behind is Europe, which holds the second-largest share of the poultry vaccines market. The European poultry sector is well-established and regulated, with a strong emphasis on producing safe and high-quality birds. In this region, the demand for effective poultry vaccinations has been pushed by stringent animal health and food safety laws.
The Asia-Pacific region has the fastest-growing poultry vaccination market. This expansion can be linked to a variety of factors, including greater poultry consumption, increased commercial poultry production, and increased knowledge of the need of immunization in disease control. Countries with enormous populations and a developing middle-class consumer base, such as China and India, are driving this rapid expansion. Furthermore, government measures targeted at increasing poultry production to fulfill increased demand for chicken products are propelling the market in this region even further.
Poultry Vaccines Market Players
Some of the top poultry vaccines companies offered in our report includes Boehringer Ingelheim International GmbH, Zoetis, Ceva Animal Health, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Ringpu Biology, Anicon GmbH, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation.
CHAPTER 1. Industry Overview of Poultry Vaccines Market
1.1. Definition and Scope
1.1.1. Definition of Poultry Vaccines
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Poultry Vaccines Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Poultry Vaccines Market By Disease
1.2.3. Poultry Vaccines Market By Product
1.2.4. Poultry Vaccines Market By Dosage Form
1.2.5. Poultry Vaccines Market By Technology
1.2.6. Poultry Vaccines Market By Application
1.2.7. Poultry Vaccines Market By End-User
1.2.8. Poultry Vaccines Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Poultry Vaccines Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Poultry Vaccines Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Poultry Vaccines Market By Disease
5.1. Introduction
5.2. Poultry Vaccines Revenue By Disease
5.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By Disease, 2020-2032
5.2.2. Avian Influenza
5.2.2.1. Avian Influenza Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Infectious Bronchitis
5.2.3.1. Infectious Bronchitis Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Newcastle Disease
5.2.4.1. Newcastle Disease Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Poultry Vaccines Market By Product
6.1. Introduction
6.2. Poultry Vaccines Revenue By Product
6.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By Product, 2020-2032
6.2.2. Attenuated Live Vaccines
6.2.2.1. Attenuated Live Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Inactivated Vaccines
6.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Subunit Vaccines
6.2.4.1. Subunit Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Recombinant Vaccines
6.2.5.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. DNA Vaccines
6.2.6.1. DNA Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Poultry Vaccines Market By Dosage Form
7.1. Introduction
7.2. Poultry Vaccines Revenue By Dosage Form
7.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By Dosage Form, 2020-2032
7.2.2. Liquid Vaccine
7.2.2.1. Liquid Vaccine Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Freeze Dried Vaccine
7.2.3.1. Freeze Dried Vaccine Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Duct
7.2.4.1. Duct Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Poultry Vaccines Market By Technology
8.1. Introduction
8.2. Poultry Vaccines Revenue By Technology
8.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By Technology, 2020-2032
8.2.2. Recombinant Vaccines
8.2.2.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Inactivated Vaccines
8.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Live Attenuated Vaccines (LAV)
8.2.4.1. Live Attenuated Vaccines (LAV) Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. Poultry Vaccines Market By Application
9.1. Introduction
9.2. Poultry Vaccines Revenue By Application
9.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By Application, 2020-2032
9.2.2. Broiler
9.2.2.1. Broiler Market Revenue (USD Million) and Growth Rate (%), 2020-2032
9.2.3. Layer
9.2.3.1. Layer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
9.2.4. Breeder
9.2.4.1. Breeder Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 10. Poultry Vaccines Market By End-User
10.1. Introduction
10.2. Poultry Vaccines Revenue By End-User
10.2.1. Poultry Vaccines Revenue (USD Million) and Forecast, By End-User, 2020-2032
10.2.2. Veterinary Hospitals
10.2.2.1. Veterinary Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
10.2.3. Poultry Firm
10.2.3.1. Poultry Firm Market Revenue (USD Million) and Growth Rate (%), 2020-2032
10.2.4. Poultry Vaccination Center
10.2.4.1. Poultry Vaccination Center Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 11. North America Poultry Vaccines Market By Country
11.1. North America Poultry Vaccines Market Overview
11.2. U.S.
11.2.1. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
11.2.2. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.3. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
11.2.4. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
11.2.5. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.6. U.S. Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
11.3. Canada
11.3.1. Canada Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
11.3.2. Canada Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.3. Canada Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
11.3.4. Canada Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
11.3.5. Canada Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.6. Canada Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
11.4. North America PEST Analysis
CHAPTER 12. Europe Poultry Vaccines Market By Country
12.1. Europe Poultry Vaccines Market Overview
12.2. U.K.
12.2.1. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
12.2.2. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.3. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
12.2.4. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
12.2.5. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.6. U.K. Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
12.3. Germany
12.3.1. Germany Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
12.3.2. Germany Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.3. Germany Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
12.3.4. Germany Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
12.3.5. Germany Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.6. Germany Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
12.4. France
12.4.1. France Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
12.4.2. France Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.3. France Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
12.4.4. France Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
12.4.5. France Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.6. France Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
12.5. Spain
12.5.1. Spain Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
12.5.2. Spain Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
12.5.3. Spain Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
12.5.4. Spain Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
12.5.5. Spain Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
12.5.6. Spain Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
12.6. Rest of Europe
12.6.1. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
12.6.2. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
12.6.3. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
12.6.4. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
12.6.5. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
12.6.6. Rest of Europe Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
12.7. Europe PEST Analysis
CHAPTER 13. Asia Pacific Poultry Vaccines Market By Country
13.1. Asia Pacific Poultry Vaccines Market Overview
13.2. China
13.2.1. China Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.2.2. China Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.2.3. China Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.2.4. China Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.2.5. China Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.2.6. China Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.3. Japan
13.3.1. Japan Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.3.2. Japan Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.3.3. Japan Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.3.4. Japan Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.3.5. Japan Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.3.6. Japan Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.4. India
13.4.1. India Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.4.2. India Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.4.3. India Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.4.4. India Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.4.5. India Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.4.6. India Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.5. Australia
13.5.1. Australia Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.5.2. Australia Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.5.3. Australia Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.5.4. Australia Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.5.5. Australia Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.5.6. Australia Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.6. South Korea
13.6.1. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.6.2. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.6.3. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.6.4. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.6.5. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.6.6. South Korea Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.7. Rest of Asia-Pacific
13.7.1. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
13.7.2. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
13.7.3. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
13.7.4. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
13.7.5. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
13.7.6. Rest of Asia-Pacific Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
13.8. Asia Pacific PEST Analysis
CHAPTER 14. Latin America Poultry Vaccines Market By Country
14.1. Latin America Poultry Vaccines Market Overview
14.2. Brazil
14.2.1. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
14.2.2. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
14.2.3. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
14.2.4. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
14.2.5. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
14.2.6. Brazil Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
14.3. Mexico
14.3.1. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
14.3.2. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
14.3.3. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
14.3.4. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
14.3.5. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
14.3.6. Mexico Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
14.4. Rest of Latin America
14.4.1. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
14.4.2. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
14.4.3. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
14.4.4. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
14.4.5. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
14.4.6. Rest of Latin America Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
14.5. Latin America PEST Analysis
CHAPTER 15. Middle East & Africa Poultry Vaccines Market By Country
15.1. Middle East & Africa Poultry Vaccines Market Overview
15.2. GCC
15.2.1. GCC Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
15.2.2. GCC Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
15.2.3. GCC Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
15.2.4. GCC Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
15.2.5. GCC Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
15.2.6. GCC Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
15.3. South Africa
15.3.1. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
15.3.2. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
15.3.3. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
15.3.4. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
15.3.5. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
15.3.6. South Africa Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
15.4. Rest of Middle East & Africa
15.4.1. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By Disease, 2020-2032
15.4.2. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By Product, 2020-2032
15.4.3. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By Dosage Form, 2020-2032
15.4.4. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032
15.4.5. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By Application, 2020-2032
15.4.6. Rest of Middle East & Africa Poultry Vaccines Revenue (USD Million) and Forecast By End-User, 2020-2032
15.5. Middle East & Africa PEST Analysis
CHAPTER 16. Player Analysis Of Poultry Vaccines Market
16.1. Poultry Vaccines Market Company Share Analysis
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Mergers And Acquisition In Global Poultry Vaccines Market
16.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 17. Company Profile
17.1. Boehringer Ingelheim International GmbH
17.1.1. Company Snapshot
17.1.2. Business Overview
17.1.3. Financial Overview
17.1.3.1. Revenue (USD Million), 2022
17.1.3.2. Boehringer Ingelheim International GmbH 2022 Poultry Vaccines Business Regional Distribution
17.1.4. Product /Service and Specification
17.1.5. Recent Developments & Business Strategy
17.2. Zoetis
17.3. Ceva Animal Health
17.4. Elanco
17.5. Merck & Co., Inc.
17.6. Hester Biosciences Limited
17.7. Ringpu Biology
17.8. Anicon GmbH
17.9. Venkys India
17.10. Calier
17.11. KM Biologics
17.12. Phibro Animal Health Corporation
